Programmed cell death in amyotrophic lateral sclerosis

Journal of Clinical Investigation

Volumn 111, Issue 2, 2003, Pages 153-161

  Guégan, Christelle ^a,b   Przedborski, Serge ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b INSERM U955   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CASPASE; DNA FRAGMENT; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CELL STRUCTURE; CYTOTOXICITY; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; MOTONEURON; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; CASPASES; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDE DISMUTASE;

EID: 0037240427     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200317610     Document Type: Review

References (77)

1. Rowland, L.P. 1995. Hereditary and acquired motor neuron diseases. In Merritt's textbook of neurology. L.P. Rowland, editor. Williams & Wilkins. Philadelphia, Pennsylvania, USA. 742-749.
2. Brown, R.H., Jr. 1995. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell. 80:687-692.
3. Deng, H.-X., et al. 1993. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 261:1047-1051.
4. Rosen, D.R., et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:59-62.
5. Cudkowicz, M.E., et al. 1997. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41:210-221.
6. Przedborski, S., et al. 1996. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration. 5:57-64.
7. Troy, C.M., and Shelanski, M.L. 1994. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc. Natl. Acad. Sci. USA. 91:6384-6387.
8. Rothstein, J.D., Bristol, L.A., Hosler, B., Brown, R.H., Jr., and Kuncl, R.W. 1994. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA. 91:4155-4159.
9. Reaume, A.G., et al. 1996. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13:43-47.
10. Gurney, M.E., et al. 1994. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 264:1772-1775.
11. Wong, P.C., et al. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14:1105-1116.
12. Bruijn, L.I., et al. 1997. ALS-linked SOD1 mutant G85R mediated damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:327-338.
13. Nagai, M., et al. 2001. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21:9246-9254.
14. Subramaniam, J.R., et al. 2002. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5:301-307.
15. Brown, R.H., Jr. 1995. Superoxide dismutase in familial amyocrophic lateral sclerosis: models for gain of function. Curr. Opin. Neurobiol. 5:841-846.
16. Chiu, A.Y., et al. 1995. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6:349-362.
17. Dal Canto, M.C., and Gurney, M.E. 1995. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 676:25-40.
18. Almer, G., Vukosavic, S., Romero, N., and Przedborski, S. 1999. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72:2415-2425.
19. Tu, P.H., et al. 1996. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA. 93:3155-3160.
20. Cleveland, D.W., and Rothstein, J.D. 2001. From Charcor to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2:806-819.
21. Beckman, J.S., Carson, M., Smith, C.D., and Koppenol, W.H. 1993. ALS, SOD and peroxynitrite. Nature. 364:584.
22. Wiedau-Pazos, M., et al. 1996. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:515-518.
23. Crow, J.P., Sampson, J.B., Zhuang, Y.X., Thompson, J.A., and Beckman, J.S. 1997. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1936-1944.
24. Estevez, A.G., et al. 1999. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 286:2498-2500.
25. Bruijn, L.I., et al. 1998. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1851-1854.
26. Durham, H.D., Roy, J., Dong, L., and Figlewicz, D.A. 1997. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS: J. Neuropathol. Exp. Neurol. 56:523-530.
27. Johnson, W.G. 2000. Late-onset neurodegenerative diseases: the role of protein insolubility. J. Anat. 196:609-616.
28. Rabizadeh, S., et al. 1995. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA. 92:3024-3028.
29. Ghadge, G.D., et al. 1997. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17:8756-8766.
30. Mena, M.A., et al. 1997. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J. Neurochem. 69:21-33.
31. Roy, N., et al. 1995. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:167-178.
32. Migheli, A., et al. 1999. Lack ofapoptosis in mice with ALS. Nat. Med. 5:966-967.
33. Pasinelli, P., Houseweart, M.K., Brown, R.H., Jr., and Cleveland, D.W. 2000. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 97:13901-13906.
34. Vukosavic, S., et al. 2000. Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 20:9119-9125.
35. Clarke, P.G.H. 1999. Apoptosis versus necrosis. In Cell death and diseases of the nervous system. V.E. Koliatsos and R.R. Ratan, editors. Humana Press. Totowa, New Jersey, USA. 3-28.
36. Yaginuma, H., et al. 1996. A novel type of programmed neuronal death in the cervical spinal cord of the chick embryo. J. Neurosci. 16:3685-3703.
37. Sperandio, S., de Belle, I., and Bredesen, D.E. 2000. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA. 97:14376-14381.
38. Martin, L.J. 1999. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 58:459-471.
39. Yoshiyama, Y., Yamada, T., Asanuma, K., and Asahi, T. 1994. Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 88:207-211.
40. Ekegren, T., Grundstrom, E., Lindholm, D., and Aquilonius, S.M. 1999. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons. Acta Neurol. Scand. 100:317-321.
41. Migheli, A., Cavalla, P., Marino, S., and Schiffer, D. 1994. A study of apoptosis in normal and pathologic nervous tissue after in situ endlabeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53:606-616.
42. He, B.P., and Strong, M.J. 2000. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits. Neuropathol. Appl. Neurobiol. 26:150-160.
43. Hiraishi, K., Suzuki, K., Hakomori, S., and Adachi, M. 1993. Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology. 3:381-390.
44. Suurmeijer, A.J., van der Wijk, J., van Veldhuisen, D.J., Yang, F., and Cole, G.M. 1999. Fractin immunostaining for the detection of apoptotic cells and apoptotic bodies in formalin-fixed and paraffin-embedded tissue. Lab. Invest. 79:619-620.
45. Rangnekar, V.M. 1998. Apoptosis mediated by a novel leucine zipper protein Par-4. Apoptosis. 3:61-66.
46. Pedersen, W.A., Luo, H., Kruman, I., Kasarskis, E., and Mattson, M.P. 2000. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. FASEB J. 14:913-924.
47. Harper, S.J., and LoGrasso, P. 2001. Signaling for survival and death in neurones. The role of stress-activated kinases, JNK and p38. Cell. Signal. 13:299-310.
48. Gupta, S. 2001. Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci. 69:2957-2964.
49. Raoul, C., et al. 2002. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-Linked SOD1 mutations. Neuron. 35:1067-1083.
50. Higgins, C.M., Jung, C., Ding, H., and Xu, Z. 2002. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J. Neurosci. 22:RC215.
51. Kong, J.M., and Xu, Z.S. 1998. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18:3241-3250.
52. Browne, S.E., et al. 1998. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J. Neurochem. 71:281-287.
53. Kroemer, G., and Reed, J.C. 2000. Mitochondrial control of cell death. Nat. Med. 6:513-519.
54. Warita, H., et al. 2001. Early decrease of survival signal-related proteins in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene. Apoptosis. 6:345-352.
55. Alexianu, M.E., Kozovska, M., and Appel, S.H. 2001. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 57:1282-1289.
56. Nguyen, M.D., Julien, J.P., and Rivest, S. 2001. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann. Neurol. 50:630-639.
57. Li, M., et al. 2000. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 288:335-339.
58. Chao, D.T., and Korsmeyer, S.J. 1998. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16:395-419.
59. Mu, X., He, J., Anderson, D.W., Trojanowski, J.Q., and Springer, J. E. 1996. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40:379-386.
60. Vukosavic, S., Dubois-Dauphin, M., Romero, N., and Przedborski, S. 1999. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 73:2460-2468.
61. Troost, D., Aten, J., Morsink, F., and De Jong, J.M.B.V. 1995. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol. Appl. Neurobiol. 21:498-504.
62. Gonzalez de Aguilar, J.L., et al. 2000. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model ofamyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol. Dis. 7:406-415.
63. Guégan, C., Vila, M., Rosoklija, G., Hays, A.P., and Przedborski, S. 2001. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21:6569-6576.
64. Kostic, V., Jackson-Lewis, V., De Bilbao, F., Dubois-Dauphin, M., and Przedborski, S. 1997. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:559-562.
65. Guégan, C., et al. 2002. Instrumental activation of Bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell. Neurosci. 20:553-562.
66. Shinoe, T., et al. 2001. Upregulation of the pro-apoptotic BH3-only peptide harakiri in spinal neurons of amyotrophic lateral sclerosis patients. Neurosci. Lett. 313:153-157.
67. Miyashita, T., et al. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799-1805.
68. Appella, E., and Anderson, C.W. 2001. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2764-2772.
69. Martin, L.J. 2000. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 7:613-622.
70. Prudlo, J., et al. 2000. Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator. Brain Res. 879:183-187.
71. Kuntz, C., Kinoshita, Y., Beal, M.F., Donehower, L.A., and Morrison, R.S. 2000. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol. 165:184-190.
72. Pasinelli, P., Borchelt, D.R., Houseweart, M.K., Cleveland, D.W., and Brown, R.H.J. 1998. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl. Acad Sci. USA. 95:15763-15768.
73. Friedlander, R.M., Brown, R.H., Gagliardini, V., Wang, J., and Yuan, J. 1997. Inhibition of ICE slows ALS in mice. Nature. 388:31.
74. Nakagawa, T., et al. 2000. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:98-103.
75. Bergeron, L., et al. 1998. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12:1304-1314.
76. Zhu, S., et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 417:74-78.
77. Zheng, T.S., et al. 2000. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6:1241-1247.